NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study
- Citation:
- J Clin Oncol vol 29 (suppl) abstr 2033
- Meeting Instance:
- ASCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2773
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- K. A. Jaeckle D. Schiff S. K. Anderson E. Galanis P. J. Stella P. J. Flynn J. N. Sarkaria B. W. Scheithauer B. J. Erickson J. C. Buckner
- Networks:
- Study
- NCCTG-N0572
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: